TL;DR
DeepAffinity introduces an interpretable deep learning framework combining recurrent and convolutional neural networks to predict compound-protein affinity from sequences, outperforming traditional methods and providing insights into drug-target interactions.
Contribution
It presents a novel semi-supervised deep learning model with integrated attention mechanisms for accurate and interpretable compound-protein affinity prediction from sequence data.
Findings
Achieves IC50 prediction error within 5-fold for test cases.
Outperforms conventional methods on benchmark datasets.
Enhances interpretability with attention mechanisms.
Abstract
Motivation: Drug discovery demands rapid quantification of compound-protein interaction (CPI). However, there is a lack of methods that can predict compound-protein affinity from sequences alone with high applicability, accuracy, and interpretability. Results: We present a seamless integration of domain knowledges and learning-based approaches. Under novel representations of structurally-annotated protein sequences, a semi-supervised deep learning model that unifies recurrent and convolutional neural networks has been proposed to exploit both unlabeled and labeled data, for jointly encoding molecular representations and predicting affinities. Our representations and models outperform conventional options in achieving relative error in IC within 5-fold for test cases and 20-fold for protein classes not included for training. Performances for new protein classes with few labeled…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
